Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients (a Phase I Study)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Natural killer cell therapy (Primary) ; Cyclophosphamide; Fludarabine
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- Acronyms INTRO
- 01 Nov 2018 Last checked against ClinicalTrials.gov record.
- 30 Aug 2018 Planned initiation date changed from 1 May 2018 to 1 Nov 2018.
- 01 Jun 2018 New trial record